IRIS
GAIDANO, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 25.446
NA - Nord America 22.076
AS - Asia 14.735
SA - Sud America 2.700
AF - Africa 443
Continente sconosciuto - Info sul continente non disponibili 73
OC - Oceania 37
Totale 65.510
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.599
RU - Federazione Russa 7.030
IE - Irlanda 5.575
SG - Singapore 4.661
CN - Cina 3.489
DE - Germania 2.934
HK - Hong Kong 2.864
SE - Svezia 2.683
UA - Ucraina 2.210
BR - Brasile 2.064
VN - Vietnam 1.828
IT - Italia 1.615
FI - Finlandia 1.193
FR - Francia 951
GB - Regno Unito 567
IN - India 478
KR - Corea 335
AR - Argentina 256
CA - Canada 244
BD - Bangladesh 172
MX - Messico 172
ID - Indonesia 145
ZA - Sudafrica 140
NL - Olanda 114
PL - Polonia 108
IQ - Iraq 106
BJ - Benin 103
JP - Giappone 102
EC - Ecuador 100
TR - Turchia 90
ES - Italia 81
AT - Austria 76
CO - Colombia 73
EU - Europa 70
IR - Iran 70
VE - Venezuela 62
BE - Belgio 61
CZ - Repubblica Ceca 56
LT - Lituania 54
PK - Pakistan 52
PY - Paraguay 50
CL - Cile 39
EG - Egitto 35
SA - Arabia Saudita 35
MA - Marocco 31
UZ - Uzbekistan 31
DZ - Algeria 30
PH - Filippine 30
MY - Malesia 29
PE - Perù 29
KE - Kenya 28
AU - Australia 26
SY - Repubblica araba siriana 26
TN - Tunisia 21
IL - Israele 18
TW - Taiwan 18
BG - Bulgaria 17
ET - Etiopia 16
JO - Giordania 16
RO - Romania 16
AE - Emirati Arabi Uniti 15
KZ - Kazakistan 15
DO - Repubblica Dominicana 14
UY - Uruguay 14
AZ - Azerbaigian 13
OM - Oman 12
TH - Thailandia 12
AL - Albania 11
CH - Svizzera 11
DK - Danimarca 11
KG - Kirghizistan 10
RS - Serbia 10
LB - Libano 9
NP - Nepal 9
NZ - Nuova Zelanda 9
BO - Bolivia 8
GR - Grecia 8
HR - Croazia 8
NG - Nigeria 8
PA - Panama 8
BH - Bahrain 7
CR - Costa Rica 6
GE - Georgia 6
HN - Honduras 6
JM - Giamaica 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
TT - Trinidad e Tobago 6
AO - Angola 5
CI - Costa d'Avorio 5
HU - Ungheria 5
MD - Moldavia 5
NI - Nicaragua 5
PS - Palestinian Territory 5
PT - Portogallo 5
SI - Slovenia 5
AM - Armenia 4
KW - Kuwait 4
LV - Lettonia 4
MK - Macedonia 4
Totale 65.444
Salva come PNG Salva come JPEG
Città #
Dublin 5.558
Jacksonville 3.930
Hong Kong 2.856
Singapore 1.984
Dearborn 1.869
San Jose 1.768
Ashburn 1.352
Chandler 1.333
Wilmington 1.278
Beijing 1.052
Moscow 942
Lawrence 733
Princeton 732
Lauterbourg 710
Ho Chi Minh City 586
San Mateo 564
Los Angeles 541
Hanoi 400
Andover 379
Buffalo 375
Piemonte 371
Seoul 314
Boardman 313
Ann Arbor 301
Houston 204
Woodbridge 199
São Paulo 197
New York 192
Novara 166
Dallas 147
Orem 145
Hefei 143
Munich 143
Redondo Beach 142
Frankfurt am Main 122
Philadelphia 118
Guangzhou 116
Düsseldorf 115
Santa Clara 114
Helsinki 112
Nanjing 112
Cotonou 103
Bremen 102
Kunming 98
Chennai 93
Norwalk 91
Mexico City 90
Tokyo 90
Warsaw 89
London 85
Montreal 84
Nuremberg 82
Milan 81
Da Nang 80
Grafing 80
Tianjin 80
Haiphong 74
Johannesburg 74
Toronto 74
Rio de Janeiro 66
Atlanta 65
Denver 65
Hangzhou 65
Poplar 63
Brooklyn 62
Chicago 61
Falkenstein 61
Stockholm 55
Brussels 54
Jinan 54
Manchester 53
Phoenix 53
Seattle 53
Turin 53
Amsterdam 52
Council Bluffs 52
Fairfield 50
Mumbai 47
Curitiba 45
Rome 45
Belo Horizonte 44
Shanghai 43
Brno 41
Nanchang 41
Jakarta 40
Vercelli 40
Brasília 39
Boston 37
Biên Hòa 36
Vienna 35
Porto Alegre 34
Quito 33
Baghdad 32
Guayaquil 32
Thái Bình 32
Dhaka 31
San Francisco 30
Fuzhou 29
Hillsboro 29
Ninh Bình 29
Totale 36.159
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 248
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 222
Comparative Analysis of the Performance of Automated Digital Cell Morphology Analyzers for Leukocyte Differentiation in Hematologic Malignancies: Mindray MC‐80 Versus West Medical Vision Hema 221
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 190
Globalisation of industry-sponsored clinical trials for breast, lung and colon cancer research: trends, threats and opportunities 185
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia 176
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 174
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 174
Analysis of human beta papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of chronic lymphocytic leukaemia patients. 171
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma 166
Benefit sharing and globalisation of industry sponsored clinical trials for breast cancer research 166
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 161
The krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 149
6q DELETIONS DEFINE DISTINCT CLINICO-PATHOLOGIC SUBSETS OF NON-HODGKIN'S LYMPHOMA 147
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 147
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 146
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 145
Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment 145
Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features. 144
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 142
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 140
Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. 139
A ROLE FOR GROWTH HORMONE AND PROLACTIN IN LEUKAEMIA AND LYMPHOMA? 139
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 136
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 136
IL LINFOMA PRIMITIVO DELLE SIEROSE E ALTRE MALATTIE LINFOPROLIFERATIVE ASSOCIATE AD HHV-8 136
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 135
Active AKT signaling triggers CLL towards Richter's transformation via over-activation of Notch1 135
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 134
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 133
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 133
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up 133
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 132
The clinical implications of gene mutations in chronic lymphocytic leukaemia 132
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 132
Factor VIII as a potential player in cancer pathophysiology 132
ANALYSIS OF HUMAN HERPESVIRUS TYPE-8 INFECTION IN AIDS-RELATED AND AIDS-UNRELATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA 131
SIMIAN AIDS-RELATED LYMPHOMA GROWTH IN SCID MICE IS INDEPENDENT OF KARYOTYPIC ABNORMALITIES OR BCL-6 MUTATIONS 130
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 130
CLINICAL IMPLICATIONS OF THE MOLECULAR GENETICS OF CHRONIC LYMPHOCYTIC LEUKEMIA 130
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 130
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 129
Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement 128
Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome 128
A NEW TAQ I POLYMORPHISM IN THE p53 GENE 128
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma 128
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 128
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial 127
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 127
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients 126
A 2-Mb YAC CONTIG LINKING THE PLASMINOGEN-APOPROTEIN(a) GENE FAMILY TO THE INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR (IGF2R) GENE ON THE TELOMERIC REGION OF CHROMOSOME 6 (6q26-q27) 125
Clinical and molecular features of mucosa-associated lymphoid tissue (MALT) lymphomas of salivary glands 123
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 122
DIAGNOSI E CLASSIFICAZIONE DEI LINFOMI NON-HODGKIN. BASI PATOLOGICHE, FENOTIPICHE E MOLECOLARI 121
ASSOCIATION OF KSHV POSITIVE PRIMARY EFFUSION LYMPHOMA WITH EXPRESSION OF THE CD138/SYNDECAN-1 ANTIGEN 121
Absence of NOTCH1 gene mutations in MALT lymphomas 121
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 121
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 121
Targeting p53 in chronic lymphocytic leukemia 121
LINFOMI NON-HODGKIN (NHL) E LINFOMA DI HODGKIN (HD) ASSOCIATI ALL'INFEZIONE DA HIV. CARATTERISTICHE EPIDEMIOLOGICHE, PATOLOGICHE, MOLECOLARI E CLINICHE NELL'ERA DELL'HAART 120
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 120
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 120
Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A 120
MOLECULAR BASES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN LIGHT OF NEW TREATMENTS 120
Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of patients with cancer who recovered from SARS-Cov-2 infection: results from the OnCovid registry. 120
HUMAN NORMAL CD5+ B LYMPHOCYTES CAN BE INDUCED TO DIFFERENTIATE TO CD5- B LYMPHOCYTES WITH GERMINAL CENTER CELL FEATURES 119
AIDS ASSOCIATED LYMPHOMAS ARE EFFICIENTLY LYSED THROUGH COMPLEMENT DEPENDENT CYTOTOXICITY (CDC) AND ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) BY RITUXIMAB 119
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study 119
The genetics of nodal marginal zone lymphoma 119
Genetic predisposition to myelodysplastic syndromes: A challenge for adult hematologists 119
Biology and treatment of Richter syndrome 118
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 118
Analysis of NOTCH1 mutations in monoclonal B cell lymphocytosis 117
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma 117
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 117
Libro universitario: Letteratura, medicina e scienze sociali. Convergenze tra culture e linguaggi; Chapter- Per un’etica della condivisione dei benefici in tema di sperimentazione dei farmaci 117
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry 116
STRUCTURAL AND FUNCTIONAL ANALYSIS OF ONCOGENES AND TUMOR SUPPRESSOR GENES IN ADULT T-CELL LEUKEMIA/LYMPHOMA SHOWS FREQUENT p53 MUTATIONS 116
EXPRESSION OF MUM-1/IRF4 SELECTIVELY CLUSTERS WITH PRIMARY EFFUSION LYMPHOMA AMONG LYMPHOMATOUS EFFUSIONS. IMPLICATIONS FOR DISEASE HISTOGENESIS AND PATHOGENESIS 116
PATTERNS OF CYTOKINE EXPRESSION IN AIDS-RELATED NON-HODGKIN'S LYMPHOMA 116
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders 116
Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma 116
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymfoproliferative disorders 116
A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation 116
ALTERAZIONI GENETICHE E INTERAZIONI CON IL MICROAMBIENTE NEI LINFOMI MALIGNI 115
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 115
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients 114
MOLECULAR INVESTIGATION OF THE CYTOKINES PRODUCED BY NORMAL AND MALIGNANT B LYMPHOCYTES 114
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia 114
Clues to the pathogenesis of Waldenström Macroglobulinemia and IgM-MGUS provided by the analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors 114
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma 114
MOLECULAR PATHOGENESIS OF NON-HODGKIN LYMPHOMA: A CLINICAL PERSPECTIVE 113
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 113
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 113
An update on: molecular genetics of high-risk chronic lymphocytic leukemia 113
European education corridors: opportunity for academic solidarity 113
MYC NETWORK MUTATIONS IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKAEMIA 112
TAQI RFLP IN THE INTERFERON GAMMA RECEPTOR 1 GENE (IFNGR1) ON HUMAN CHROMOSOME 6q 112
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 112
14q32 Translocations and risk of Richter transformation in chronic lymphocytic leukaemia 112
Totale 13.232
Salva come PNG Salva come JPEG
Categoria #
all - tutte 332.146
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 332.146
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.033 0 0 0 0 0 0 0 0 0 66 826 141
2021/20224.996 122 26 992 587 342 78 488 117 325 140 805 974
2022/202310.113 807 313 461 399 575 833 201 459 5.554 29 298 184
2023/20243.104 241 214 246 76 585 50 630 78 23 41 215 705
2024/20258.283 182 63 257 173 245 473 646 843 2.767 882 332 1.420
2025/202624.311 1.029 893 2.116 3.717 1.947 2.021 4.094 4.696 2.289 1.509 0 0
Totale 66.362